Project Grant R01DE033038
Award Date
7/16/24
Completion Date
4/30/29
Dollars Obligated
$2.8M
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
This $229,440 Project Grant was awarded on August 13, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The grant supports research to investigate the divergent responses to a combination of radiation therapy, PD1-IL2V immunocytokine, and OX40 agonist therapy in preclinical models of head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC). The research...
This federal Project Grant award, totaling $164,322, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award supports research to investigate the mechanism by which myeloid cells in pre-cancerous oral lesions develop a suppressive phenotype, which inhibits the anti-tumor immune response. The research aims to develop strategies to intercept the evolution of these pro-tumoral myeloid cells,...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $628,965 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Icahn School of Medicine at Mount Sinai. The grant, with a performance period from May 1, 2025 to April 30, 2030, supports research to elucidate how immune cells in the salivary gland niche regulate epithelial cell processes. The goal is to identify novel immune-specific mediators of salivary gland epithelial cellular...
The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $1,880,856 Project Grant to The Ohio State University to support research on the role of the oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes. The 5-year project, which began on Sep 4, 2024, aims to: Define the impact of glucocorticoids and the glucocorticoid inactivating enzyme...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $390,000.00 in funding to The Medical College of Wisconsin, Inc. for the project "LEVERAGING SINGLE-CELL CO-CULTURE AND GENE EXPRESSION PROFILING TO IDENTIFY TUMOR ANTIGEN-SPECIFIC T CELLS IN ORAL CANCER." The project aims to develop innovative techniques to identify and expand tumor-infiltrating...
This federal Project Grant award of $339,000 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The funding supports research by New York University School of Medicine to investigate the role of autocrine cholinergic signaling in maintaining memory T cell responses in oral squamous cell carcinoma. The research project will be conducted from August 1, 2024 to July 31, 2026. As a leading...
This $170,208 four-year Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will support research aimed at defining the mechanisms through which polyamines (PAs) modulate anti-tumor immunity in head and neck squamous cell carcinoma (HNSC). The research will utilize quantitative histology, mass spectrometry imaging, in vitro cell culture models, metabolomics, and in vivo HNSC mouse...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), will fund research to define oral squamous cell carcinoma (OSCC)-associated microbiome and metabolome signatures and determine if microbiota transfer from OSCC patients to mouse models promotes tumorigenesis. The $234,000 award to the University of Colorado-Denver will extend previous studies on the role of the human...
This federal Project Grant award of $999,776.00, awarded on Sep 13, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to advance oral health equity through integrated research approaches. The goal is to strengthen the scientific basis for innovations in population-level strategies to improve dental care access, utilization, and quality. The research will focus on historically underrepresented...
This $2,796,216 Project Grant award from the National Institute of Dental and Craniofacial Research (CFDA 93.121 - Oral Diseases and Disorders Research) supports research to determine the mechanisms of action of p53 and p300 reactivation in response to the compound OHM1 for the treatment of human papillomavirus (HPV)-positive oropharyngeal cancer (OPC). The research aims to: 1) Evaluate how OHM1 modulates the p53 post-translational modification code to control p53 functionality and levels, and...